Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Evolocumab biosimilar by Cinnagen for Hyperlipidemia: Likelihood of Approval
Evolocumab biosimilar is under clinical development by Cinnagen and currently in Phase III for Hyperlipidemia. According to GlobalData, Phase III...